Bioprinting during surgery of bone constructs used as a controlled gene...
Bioprinting during surgery of bone constructs used as a controlled gene co-delivery platform for the repair of skull defects

Image credit: Dong Heo, Kyung Hee University; Ozbolat Lab, Penn State. / Penn State (CC BY-NC-ND 4.0)

News • Healing support

Bioprinting for bone repair improved with genes

Given enough time and energy, the body will heal, but when doctors or engineers intervene, the processes do not always proceed as planned because chemicals that control and facilitate the healing process are missing. Now, an international team of engineers is bioprinting bone along with two growth factor encoding genes that help incorporate the cells and heal defects in the skulls of rats.

"Growth factors are essential for cell growth," said Ibrahim T. Ozbolat, associate professor of engineering science and mechanics. "We use two different genes encoding two different growth factors. These growth factors help stem cells to migrate into the defect area and then help the progenitor cells to convert into bone."

The researchers used gene encoding PDGF-B, platelet derived-growth factor, which encourages cells to multiply and to migrate, and gene encoding BMP-2, bone morphogenetic protein, which improves bone regeneration. They delivered both genes using bioprinting. "We used a controlled co-delivery release of plasmids from a gene-activated matrix to promote bone repair," the researchers stated in the journal Biomaterials.

Ozbolat and his team embedded the DNA for the protein in plasmids — ringlike loops of DNA that can transport genetic information. Once the DNA enters the progenitor cell, it begins to produce the appropriate proteins to enhance bone growth. The two genes were printed during surgery onto a hole in the skull of a rat using a device very similar to an ink-jet printer. The mixture was created to release a burst of PDGF-B encoding gene in 10 days and a continuing release of BMP-2 encoding gene for five weeks. 

The rats that received bioprinted genes with controlled release of BMP-2 encoding gene saw about 40% bone tissue creation and 90% bone coverage in six weeks compared to 10% new bone tissue and 25% bone coverage for rats with the same defect, but no treatment. "This method is better than simply dumping the growth factors," said Ozbolat. "If we do that, the amounts of proteins are finite, but if we use gene therapy, the cells continue to produce the necessary growth factors." 

Source: Pennsylvania State University


More on the subject:
Read all latest stories

Related articles


News • Dermatology prototype

3D skin bioprinting shows potential for eczema treatment

Researchers at Mayo Clinic have developed a 3D prototype of human skin bioprinted to model inflammatory skin disease such as atopic dermatitis — more commonly known as eczema.


News • New printing method

Self-folding 4D electrodes enhance nerve stimulation

Using 4D printing technology, researchers have developed flexible electrodes. On contact with moisture, they automatically fold and wrap themselves around thin nerves.


News • Size-changing and personalised

Researchers create 4D printed implants for efficient breast cancer management

Researchers from Queen’s University Belfast have created personalised 4D printed “smart” implants for breast cancer management - a first for this technology.

Related products

DryPro 873


Konica Minolta · DryPro 873

Konica Minolta Business Solutions Europe GmbH
DryPro Sigma I


Konica Minolta · DryPro Sigma I

Konica Minolta Business Solutions Europe GmbH
DryPro Sigma II


Konica Minolta · DryPro Sigma II

Konica Minolta Business Solutions Europe GmbH
Subscribe to Newsletter